GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardiff Oncology Inc (STU:XE7C) » Definitions » Cyclically Adjusted FCF per Share

Cardiff Oncology (STU:XE7C) Cyclically Adjusted FCF per Share : €-30.69 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cardiff Oncology Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Cardiff Oncology's adjusted free cash flow per share for the three months ended in Mar. 2024 was €-0.161. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-30.69 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Cardiff Oncology was 3.50% per year. The lowest was 3.50% per year. And the median was 3.50% per year.

As of today (2024-05-21), Cardiff Oncology's current stock price is €3.265. Cardiff Oncology's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €-30.69. Cardiff Oncology's Cyclically Adjusted Price-to-FCF of today is .


Cardiff Oncology Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Cardiff Oncology's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiff Oncology Cyclically Adjusted FCF per Share Chart

Cardiff Oncology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -28.16 -31.71 -31.80 -28.07

Cardiff Oncology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.07 -30.81 -29.99 -28.07 -30.69

Competitive Comparison of Cardiff Oncology's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Cardiff Oncology's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardiff Oncology's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cardiff Oncology's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Cardiff Oncology's Cyclically Adjusted Price-to-FCF falls into.



Cardiff Oncology Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cardiff Oncology's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.161/131.7762*131.7762
=-0.161

Current CPI (Mar. 2024) = 131.7762.

Cardiff Oncology Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -7.356 100.560 -9.640
201409 -10.357 100.428 -13.590
201412 -12.135 99.070 -16.141
201503 -15.185 99.621 -20.086
201506 -15.333 100.684 -20.068
201509 -12.546 100.392 -16.468
201512 -17.074 99.792 -22.546
201603 -15.615 100.470 -20.481
201606 -17.964 101.688 -23.279
201609 -15.171 101.861 -19.627
201612 -20.052 101.863 -25.941
201703 -19.067 102.862 -24.427
201706 -9.533 103.349 -12.155
201709 -11.125 104.136 -14.078
201712 -4.982 104.011 -6.312
201803 -3.017 105.290 -3.776
201806 -2.250 106.317 -2.789
201809 -0.868 106.507 -1.074
201812 -0.829 105.998 -1.031
201903 -0.729 107.251 -0.896
201906 -0.563 108.070 -0.687
201909 -0.490 108.329 -0.596
201912 -0.353 108.420 -0.429
202003 -0.308 108.902 -0.373
202006 -0.263 108.767 -0.319
202009 -0.128 109.815 -0.154
202012 -0.115 109.897 -0.138
202103 -0.133 111.754 -0.157
202106 -0.092 114.631 -0.106
202109 -0.117 115.734 -0.133
202112 -0.161 117.630 -0.180
202203 -0.219 121.301 -0.238
202206 -0.153 125.017 -0.161
202209 -0.185 125.227 -0.195
202212 -0.201 125.222 -0.212
202303 -0.181 127.348 -0.187
202306 -0.153 128.729 -0.157
202309 -0.173 129.860 -0.176
202312 -0.147 129.419 -0.150
202403 -0.161 131.776 -0.161

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Cardiff Oncology  (STU:XE7C) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Cardiff Oncology Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Cardiff Oncology's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardiff Oncology (STU:XE7C) Business Description

Industry
Traded in Other Exchanges
Address
11055 Flintkote Avenue, San Diego, CA, USA, 92121
Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.

Cardiff Oncology (STU:XE7C) Headlines

No Headlines